Fate Therapeutics's Dividends per Share for the
three
months ended in Dec. 2023 was $0.00.
The historical rank and industry rank for Fate Therapeutics's 3-Year Dividend Growth Rate or its related term are showing as below:
FATE's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 13 * Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Fate Therapeutics's Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00. As of today, Fate Therapeutics's Dividend Yield % is 0.00%.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Fate Therapeutics's 3-Year Dividend Growth Rate
For the Biotechnology subindustry, Fate Therapeutics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fate Therapeutics's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fate Therapeutics's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Fate Therapeutics's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fate Therapeutics 3-Year Dividend Growth Rate Related Terms>
Fate Therapeutics (Fate Therapeutics) Business Description
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FATE has been successfully added to your